| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |